.
"to be honest, that was what i had almost expected," she said..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..�we are glad that, at last, the commission is taking serious steps to fight air pollution before the court of justice,� clientearth lawyer ugo taddei said in a press release..
.